Drug Topics June 2021

Although COVID-19 remains a real threat, it seems we are now progressing toward a return to normalcy thanks to the widespread availability of vaccines and tireless efforts of our health care workers.

Viloxazine is a selective norepinephrine reuptake inhibitor and is the first new nonstimulant medication for treatment of ADHD in children in more than 10 years.

Many Americans still do not want to get vaccinated. Vaccine myths spread on the internet are a major part of the problem.

An increasing number of pharmacists are now prescribing birth control, further expanding their role as public health service providers.

What independent pharmacists need to know.

Migraines can be disabling for those affected, but various pharmacologic and nonpharmacologic therapies are available.

Addressing the needs of LGBTQ+ patients requires insight, innovation, and introspection.

Exposure to heat and sun can worsen symptoms for certain conditions.

Smart tech improves medication management and workflow.